# The Contralateral Lung: An Opportunity for Lung Transplant at a Lower Lung Allocation Score?

**Authors:** Emily L. Larson, Jessica M. Ruck, Alexandra Rizaldi, Alice L. Zhou, Alfred J. Casillan, Jinny S. Ha, Christian A. Merlo, Errol L. Bush

PMC · DOI: 10.1016/j.atssr.2024.11.001 · Annals of Thoracic Surgery Short Reports · 2024-11-13

## TL;DR

This study shows that using the contralateral lung in single-lung transplants can allow for transplants at lower scores without harming patient survival.

## Contribution

The study demonstrates that contralateral lungs can be used effectively at lower Lung Allocation Scores, potentially expanding donor availability.

## Key findings

- Contralateral lung recipients had a lower median Lung Allocation Score than first single-lung transplant recipients.
- Contralateral lung recipients showed higher survival rates compared to first single-lung transplant recipients.
- The use of contralateral lungs could help expand the donor pool without compromising transplant outcomes.

## Abstract

In more than half of single-lung transplants (SLTs), the second or contralateral lung is discarded. We evaluated the use of the contralateral lung and its role in enabling single-lung transplantation at a lower Lung Allocation Score (LAS).

We identified adult SLT recipients from 2015 to 2022 using the United Network for Organ Sharing/Organ Procurement and Transplantation Network database. Post-SLT survival was compared with Kaplan-Meier curves and multivariable Cox regression.

Of 4692 SLT recipients, 1246 (26.6%) received a contralateral lung. Contralateral lung recipients had a lower median LAS (36.9 [33.5-42.2] vs 40.4 [35.3-49.8]; P < .001) and higher median sequence number (26 [11-65.8] vs 8 [3-25]; P < .001). Survival was higher in contralateral vs first SLT recipients (median survival, 5.0 [95% CI, 4.7-5.3] years vs 4.5 [95% CI, 4.2-4.7] years; log-rank P < .001). This difference persisted as a 14% decreased hazard of mortality for contralateral recipients after adjustment (adjusted hazard ratio, 0.86 [0.77-0.95]; P = .004). Of SLT donors, 1309 (37.4%) had both lungs accepted for use.

In this nationwide analysis, we found that contralateral SLT recipients received SLTs at a lower median LAS without compromising outcomes, suggesting that contralateral single-lung transplantation may provide a valuable approach to help expand the donor pool.

## Full-text entities

- **Diseases:** trauma (MESH:D014947), cardiac death (MESH:D003643), infection (MESH:D007239), SLTs (MESH:D008171), CF (MESH:D003550), obstructive lung disease (MESH:D008173), emphysema (MESH:D004646), COPD (MESH:D029424), ischemia (MESH:D007511)
- **Chemicals:** SLT (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12167541/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12167541/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12167541/full.md

---
Source: https://tomesphere.com/paper/PMC12167541